Aroa Biosurgery (ASX: ARX) – soft-tissue regeneration
COMPANY SCOREBOARD
| Pro Plus | Pro | Con Plus | Con |
|
|
|
ABOUT COMPANY
Aroa Biosurgery (ARX) (https://aroa.com/) is a soft-tissue regeneration company in NZ that develops, manufactures, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction
CAPITAL STRUCTURE
| ASX Code | Share Price | Shares | Option (In) | Market Cap | Cash/Asset ($m) |
| ARX | 0.62 | 344207834 | 8830992 | 218884072.12 | 46.9/75 |
| Holders No | Top 20 (Cur) | Top 20 (Pre) | Director Hold | Performance Right | Note |
| 3609 | 76.21% | 72.51% | 16.77% |
Several institutions have quietly built some stakes.
BUSINESS
Below is the company’s five years performance:
| ARX | 2024 | 2023 | 2022 | 2021 | 2020 |
| Operation Revenue | 69066 | 63360 | 39680 | 22342 | |
| Cost of Sale | -10093 | -9884 | -9377 | -6818 | |
| Gross Revenue | 58973 | 53476 | 30303 | 15524 | 0 |
| Gross Margin | 0.8539 | 0.8440 | 0.7637 | 0.6948 | 0 |
| Overheads | -71308 | -58321 | -39062 | -28184 | |
| Fixed Overheads | |||||
| Variable Overheads | |||||
| Total Operation Expense | -71308 | -58321 | -39062 | -28184 | 0 |
| Operation Profit | -12335 | -4845 | -8759 | -12660 | 0 |
| Other Revenue | 1943 | 427 | 386 | -4384 | |
| Interest Expense | 244 | 2727 | -618 | -1111 | |
| D&A | |||||
| Income Tax | -201 | -12 | -125 | -107 | |
| Net Profit | -10349 | -1703 | -9116 | -18262 | 0 |
| NOTES | Revenue all in USA |
Tela Bio partnership made more than half of the sales in FY22.
SUMMARY
The company will be a good defensive stock to hold if the market comes down in CY24. 50c W bottom seems solid.